Second, KRASmut NSCLC cell models display a range of sensitivity to EGFR and AURKA inhibition; however, the degree of sensitivity in vitro does not correspond directly to expression of the EGFR or AURKA protein, or TP53 mutation status. The gene discussed is AURKA; the disease is non-small cell lung carcinoma.